Author Affiliations: Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, Maryland (Dr Emanuel); Department of Economics (Dr Fuchs) and Center for Health Policy (Dr Garber), Stanford University, Palo Alto, California; and VA Palo Alto Health Care System, Palo Alto, California (Dr Garber).
The mismatch between US health expenditures and the resources devoted to learning which health interventions are most effective is both striking and unwise. Each year US individuals spend more than $2 trillion on health care.1 More than $100 billion is spent for research and development and for regulatory approval of new technologies. Yet total spending on technology assessment almost certainly falls short of $1 billion per year—0.05% of all US health care spending.
Emanuel EJ, Fuchs VR, Garber AM. Essential Elements of a Technology and Outcomes Assessment Initiative. JAMA. 2007;298(11):1323–1325. doi:10.1001/jama.298.11.1323